{"id":62155,"title":"Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110?, for relapsed/refractory chronic lymphocytic leukemia.","abstract":"","date":"2014-05-30","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24615777","annotations":[{"name":"Chronic (medicine)","weight":0.783378,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Enzyme inhibitor","weight":0.759037,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Leukemia","weight":0.637284,"wikipedia_article":"http://en.wikipedia.org/wiki/Leukemia"},{"name":"Kinase","weight":0.636844,"wikipedia_article":"http://en.wikipedia.org/wiki/Kinase"},{"name":"Lymphocyte","weight":0.598448,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphocyte"},{"name":"Phosphatidylinositol","weight":0.105101,"wikipedia_article":"http://en.wikipedia.org/wiki/Phosphatidylinositol"},{"name":"B-cell chronic lymphocytic leukemia","weight":0.102778,"wikipedia_article":"http://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia"},{"name":"Lymphoid leukemia","weight":0.0137802,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoid_leukemia"}]}
